XML 22 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Shares [Member]
Paid-in Capital [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Treasury Shares [Member]
Noncontrolling Interest [Member]
Balance at Dec. 31, 2012 $ 5,848.0 $ 2.6 $ 3,500.6 $ 7,143.2 $ 268.3 $ (5,072.1) $ 5.4
Balance, shares at Dec. 31, 2012   257.1       (85.5)  
Net earnings 778.6     780.4     (1.8)
Other comprehensive income (loss) 32.4       32.6   (0.2)
Purchase of additional shares from noncontrolling interest (1.7)   (1.1)       (0.6)
Cash dividends declared (135.4)     (135.4)      
Stock compensation plans, including tax benefits 507.7   501.1 1.2   $ 5.4  
Stock compensation plans, including tax benefits, shares   7.2       0.1  
Share repurchases (719.0)         $ (719.0)  
Share repurchases, shares           (9.1)  
Balance at Dec. 31, 2013 6,310.6 $ 2.6 4,000.6 7,789.4 300.9 $ (5,785.7) 2.8
Balance, shares at Dec. 31, 2013   264.3       (94.5)  
Net earnings 719.2     720.3     (1.1)
Other comprehensive income (loss) (262.7)       (262.8)   0.1
Cash dividends declared (148.6)     (148.6)      
Stock compensation plans, including tax benefits 333.7 $ 0.1 330.1 1.0   $ 2.5  
Stock compensation plans, including tax benefits, shares   4.1          
Share repurchases (400.5)         $ (400.5)  
Share repurchases, shares           (4.2)  
Balance at Dec. 31, 2014 6,551.7 $ 2.7 4,330.7 8,362.1 38.1 $ (6,183.7) 1.8
Balance, shares at Dec. 31, 2014   268.4       (98.7)  
Net earnings 146.2     147.0     (0.8)
Other comprehensive income (loss) (366.6)       (367.1)   0.5
Cash dividends declared (164.4)     (164.4)      
Stock compensation plans, including tax benefits 149.8   142.2 3.0   $ 4.6  
Stock compensation plans, including tax benefits, shares   1.6       0.1  
Share repurchases $ (150.0)         $ (150.0)  
Share repurchases, shares (1.4)         (1.4)  
Biomet merger consideration $ 3,722.7 $ 0.3 3,722.4        
Biomet merger consideration, shares   32.7          
Balance at Dec. 31, 2015 $ 9,889.4 $ 3.0 $ 8,195.3 $ 8,347.7 $ (329.0) $ (6,329.1) $ 1.5
Balance, shares at Dec. 31, 2015   302.7       (100.0)